Matches in SemOpenAlex for { <https://semopenalex.org/work/W2041355950> ?p ?o ?g. }
- W2041355950 endingPage "6154" @default.
- W2041355950 startingPage "6145" @default.
- W2041355950 abstract "B cells are involved in the pathogenesis of chronic GVHD (cGVHD). We hypothesized that prophylactic anti-B-cell therapy delivered 2 months after transplantation would decrease allogeneic donor B-cell immunity and possibly the incidence of cGVHD. Therefore, in the present study, patients with high-risk chronic lymphocytic leukemia (n = 22) and mantle-cell lymphoma (n = 13) received a total lymphoid irradiation of 80 cGy for 10 days and antithymocyte globulin 1.5 mg/kg/d for 5 days. Rituximab (375 mg/m(2)) was infused weekly on days 56, 63, 70, and 77 after transplantation. The incidence of acute GVHD was 6%. The cumulative incidence of cGVHD was 20%. Nonrelapse mortality was 3%. Rituximab treatment after allogeneic transplantation significantly reduced B-cell allogeneic immunity, with complete prevention of alloreactive H-Y Ab development in male patients with female donors (P = .01). Overall survival and freedom from progression at 4 years for chronic lymphocytic leukemia patients were 73% and 47%, respectively; for mantle-cell lymphoma patients, they were 69% and 53%, respectively." @default.
- W2041355950 created "2016-06-24" @default.
- W2041355950 creator A5005492422 @default.
- W2041355950 creator A5008947160 @default.
- W2041355950 creator A5012049620 @default.
- W2041355950 creator A5012405884 @default.
- W2041355950 creator A5012590130 @default.
- W2041355950 creator A5013880130 @default.
- W2041355950 creator A5014659823 @default.
- W2041355950 creator A5016275445 @default.
- W2041355950 creator A5025803819 @default.
- W2041355950 creator A5038377091 @default.
- W2041355950 creator A5040662951 @default.
- W2041355950 creator A5048756978 @default.
- W2041355950 creator A5053002300 @default.
- W2041355950 creator A5060910250 @default.
- W2041355950 creator A5064062205 @default.
- W2041355950 creator A5070553243 @default.
- W2041355950 creator A5081926380 @default.
- W2041355950 date "2012-06-21" @default.
- W2041355950 modified "2023-10-02" @default.
- W2041355950 title "Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence" @default.
- W2041355950 cites W107716097 @default.
- W2041355950 cites W1520859596 @default.
- W2041355950 cites W1969261714 @default.
- W2041355950 cites W1975141436 @default.
- W2041355950 cites W1980914191 @default.
- W2041355950 cites W1995326684 @default.
- W2041355950 cites W2006493080 @default.
- W2041355950 cites W2009638683 @default.
- W2041355950 cites W2011578371 @default.
- W2041355950 cites W2011675173 @default.
- W2041355950 cites W2019905067 @default.
- W2041355950 cites W2020491471 @default.
- W2041355950 cites W2025784324 @default.
- W2041355950 cites W2030937557 @default.
- W2041355950 cites W2033466930 @default.
- W2041355950 cites W2038116051 @default.
- W2041355950 cites W2039904206 @default.
- W2041355950 cites W2041925366 @default.
- W2041355950 cites W2042030389 @default.
- W2041355950 cites W2043799126 @default.
- W2041355950 cites W2064840987 @default.
- W2041355950 cites W2065057275 @default.
- W2041355950 cites W2066519436 @default.
- W2041355950 cites W2074584895 @default.
- W2041355950 cites W2085237950 @default.
- W2041355950 cites W2089862102 @default.
- W2041355950 cites W2101175123 @default.
- W2041355950 cites W2103255742 @default.
- W2041355950 cites W2104940816 @default.
- W2041355950 cites W2106495043 @default.
- W2041355950 cites W2110395869 @default.
- W2041355950 cites W2133201432 @default.
- W2041355950 cites W2138313532 @default.
- W2041355950 cites W2139184776 @default.
- W2041355950 cites W2142099365 @default.
- W2041355950 cites W2143749371 @default.
- W2041355950 cites W2143755862 @default.
- W2041355950 cites W2161938736 @default.
- W2041355950 cites W2164199065 @default.
- W2041355950 cites W2618073389 @default.
- W2041355950 cites W3549150 @default.
- W2041355950 cites W37609260 @default.
- W2041355950 cites W4293241248 @default.
- W2041355950 doi "https://doi.org/10.1182/blood-2011-12-395970" @default.
- W2041355950 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3383022" @default.
- W2041355950 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22563089" @default.
- W2041355950 hasPublicationYear "2012" @default.
- W2041355950 type Work @default.
- W2041355950 sameAs 2041355950 @default.
- W2041355950 citedByCount "98" @default.
- W2041355950 countsByYear W20413559502012 @default.
- W2041355950 countsByYear W20413559502013 @default.
- W2041355950 countsByYear W20413559502014 @default.
- W2041355950 countsByYear W20413559502015 @default.
- W2041355950 countsByYear W20413559502016 @default.
- W2041355950 countsByYear W20413559502017 @default.
- W2041355950 countsByYear W20413559502018 @default.
- W2041355950 countsByYear W20413559502019 @default.
- W2041355950 countsByYear W20413559502020 @default.
- W2041355950 countsByYear W20413559502021 @default.
- W2041355950 countsByYear W20413559502022 @default.
- W2041355950 countsByYear W20413559502023 @default.
- W2041355950 crossrefType "journal-article" @default.
- W2041355950 hasAuthorship W2041355950A5005492422 @default.
- W2041355950 hasAuthorship W2041355950A5008947160 @default.
- W2041355950 hasAuthorship W2041355950A5012049620 @default.
- W2041355950 hasAuthorship W2041355950A5012405884 @default.
- W2041355950 hasAuthorship W2041355950A5012590130 @default.
- W2041355950 hasAuthorship W2041355950A5013880130 @default.
- W2041355950 hasAuthorship W2041355950A5014659823 @default.
- W2041355950 hasAuthorship W2041355950A5016275445 @default.
- W2041355950 hasAuthorship W2041355950A5025803819 @default.
- W2041355950 hasAuthorship W2041355950A5038377091 @default.
- W2041355950 hasAuthorship W2041355950A5040662951 @default.
- W2041355950 hasAuthorship W2041355950A5048756978 @default.
- W2041355950 hasAuthorship W2041355950A5053002300 @default.